Zydus Lifesciences extends Sterling Biotech API business acquisition deadline to Sept 30
Pharmaceutical company Zydus Lifesciences Ltd on Monday (June 29) said it has extended the closing date for the acquisition of the active pharmaceutical ingredient (API) business of Sterling Biotech Ltd to September 30, 2026, as the seller is yet to complete certain conditions precedent under the Business Transfer Agreement (BTA). “We hereby inform that Sterling…
